Health insurance prior authorization policy, approved medication lists, and network pharmacy policies complicate maintaining continuous access during the DEA-imposed artificial shortage by complicating transferring prescriptions to pharmacies that have supply available and transferring prescriptions to substantially-equivalent drugs sold by different manufacturers.